Health-related quality of life in men with metastatic prostate cancer: The misleading effect of lead-time bias

BJU International

Volumn 91, Issue 1, 2003, Pages 9-13

  Litwin, M S ^a,d   Saigal, C S ^a   Lubeck, D P ^b   Li, Y P ^b   Henning, J M ^c   Carroll, P R ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c TAP PHARMACEUTICAL PRODUCTS INC   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Epidemiology; Incidence; Outcomes; Pelvic radiation; Prostate cancer; Quality of life; Radical prostatectomy

Indexed keywords

AGED; ARTICLE; CANCER RISK; CANCER SCREENING; CONTROLLED STUDY; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL DECISION MAKING; METASTASIS; PATIENT COUNSELING; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATECTOMY; QUALITY OF LIFE; SCORING SYSTEM; COHORT ANALYSIS; COMORBIDITY; ETHNOLOGY; GROUPS BY AGE; HEALTH SURVEY; MULTIVARIATE ANALYSIS; SHORT FORM 36; UNITED STATES;

AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; BIAS (EPIDEMIOLOGY); COHORT STUDIES; HUMANS; MALE; MIDDLE AGED; NEOPLASM METASTASIS; PROSTATIC NEOPLASMS; QUALITY OF LIFE; QUESTIONNAIRES;

EID: 0037232238     PISSN: 14644096     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1464-410X.2003.04010.x     Document Type: Article

References (11)

1. Dennis LK, Resnick MI. Analysis of recent trends in prostate cancer incidence and mortality. Prostate 2000; 42: 247-52
2. Brawley OW. Prostate carcinoma incidence and patient mortality: the effects of screening and early detection. Cancer 1997; 80: 1857-63
3. Lubeck DP, Litwin MS, Henning JM et al. The CaPSURE database. a methodology for clinical practice and research in prostate cancer. CaPSURE Research Panel. Cancer of the Prostate Strategic Urologic Research Endeavor. Urology 1996; 48: 773-7
4. Ware JE Jr, Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care 1992; 30: 473-83
5. The Medical Research Council Prostate Cancer Working Party Investigators Group. Immediate versus deferred treatment for advanced prostatic cancer: initial results of the Medical Research Council Trial. Br J Urol 1997; 79: 235-46
6. Albertsen PC, Aaronson NK, Muller MJ, Keller SD, Ware JE Jr. Health-related quality of life among patients with metastatic prostate cancer. Urology 1997; 49: 207-16
7. Litwin MS, Shpall AI, Dorey F, Nguyen TH. Quality-of-life outcomes in long-term survivors of advanced prostate cancer. Am J Clin Oncol 1998; 21: 327-32
8. Schroder FH, Collette L, de Reijke TM, Whelan P. Prostate cancer treated by anti-androgens. is sexual function preserved? EORTC Genitourinary Group. European Organization for Research and Treatment of Cancer. Br J Cancer 2000; 82: 283-90
9. Schag CA, Ganz PA, Wing DS, Sim MS, Lee JJ. Quality of life in adult survivors of lung, colon and prostate cancer. Qual Life Res 1994; 3: 127-41
10. Herr HW, Kornblith AB, Ofman U. A comparison of the quality of life of patients with metastatic prostate cancer who received or did not receive hormonal therapy. Cancer 1993; 71 (Suppl. 3): 1143-50
11. Knight SJ, Chmiel JS, Kuzel T et al. Quality of life in metastatic prostate cancer among men of lower socioeconomic status: feasibility and criterion related validity of 3 measures. J Urol 1998; 160: 1765-9